Screener / SEC EDGAR /CIK 0001360604 /10-K filed Feb 13, 2026, compared with Feb 19, 2025 /Numbers from the XBRL of the 10-Ks
NYSE Real estate · REIT

Healthcare Realty Trust Inc HR

Compare with peers Embed
The 10-K against last year's

94 changes: 16 added, 29 removed, 48 reworded, 1 quiet changes

10-K Feb 13, 2026 vs Feb 19, 2025

10-K 0001360604-26-000018 (Feb 13, 2026) vs 10-K 0001360604-25-000032 (Feb 19, 2025)

Every paragraph, and how much of it changed

One bar per paragraph, in the order of the 10-K. Height and colour show the share of its words not in the closest paragraph a year earlier; the tallest bars are new paragraphs.

Risk Factors

151 paragraphs · 3 new · 30 reworded · 5 gone · 10-K Feb 13, 2026 against Feb 19, 2025
New paragraph Reworded (5% of its words or more) Same or nearly
Paragraph 9 · 47% changed Every version of it
On January 11, 2025, As previously disclosed, Prospect Medical Holdings (“Prospect”) filed petitions for relief under Chapter 11 of the U.S. Bankruptcy Code in the U.S. Bankruptcy Court for the Northern District January of Texas. 2025. Prospect leases leased approximately 80,912 square feet of space from the Company, accounting Company. In October 2025, a subsidiary of Hartford HealthCare (“Hartford Health”) was selected as the successful bidder for approximately $2.9 million of annual rental revenue. the Prospect assets associated with the Company’s Prospect leases. The Company moved to cash basis accounting for these signed direct leases with Hartford Heath totaling 65,477 square feet effective January 1, 2026 and recorded a revenue reduction of $0.7 million retained certain sublet in the fourth quarter. additional spaces. There can be is no assurance that the Company will recover unpaid rent from Prospect or be able to timely relet the remaining Prospect leased space related to any rejected leases. that was not assumed by Hartford Health.
Paragraph 147 · 43% changed Every version of it
A REIT's net gain from prohibited transactions is subject to a 100% tax. In general, prohibited transactions are sales or other dispositions of property held primarily for sale to customers in the ordinary course of business. The Company may be subject to the prohibited transaction tax equal to 100% of net gain upon the disposition of real property. Although a safe harbor to the characterization of the sale of real property by a REIT as a prohibited transaction is available, there can be no assurance that the Company can comply in all cases with the safe harbor or that it will avoid owning property that may be characterized as held primarily for sale to customers in the ordinary course of business. Consequently, the Company may choose not to engage in certain sales of its properties or may conduct such sales through a taxable REIT subsidiary, which would be subject to federal and state income taxation.
Paragraph 45 · 41% changed Every version of it
Most of the Company’s properties on or adjacent to hospital campuses are largely dependent on the viability of the health system’s campus where they are located, whether or not the hospital or health system is a tenant in such properties. The viability of these health systems depends on factors such as the quality and mix of healthcare services provided, competition, payor mix, demographic trends in the surrounding community, market position and growth potential. If one of these hospitals is unable to meet its financial obligations, is unable to compete successfully, or is forced to close or relocate, the Company’s properties on or near such hospital campus could be adversely impacted.
Paragraph 95 · 39% changed Every version of it
Further, the Company obtains credit ratings from various credit-rating agencies based on their evaluation of the Company's credit. These agencies' ratings are based on a number of factors, some of which are not within the Company's control. In addition to factors specific to the Company's financial strength and performance, the rating agencies also consider conditions affecting REITs generally. The Company's credit ratings could be downgraded. If the Company's credit ratings are downgraded or other negative action is taken, the Company could be required, among other things, to pay additional interest and fees on borrowings under the Unsecured Credit Facility.
Paragraph 116 · 31% changed Every version of it
Trends in the healthcare service industry industry, including the impact of the One Big Beautiful Bill Act passed during 2025 that is subject of ongoing analysis, may negatively affect the demand for the Company’s properties, lease revenues and the values of its investments.
Paragraph 111 · 27% changed Every version of it
Revenue Code, because it is not entirely clear whether a forward equity agreement qualifies as a "securities futures contract," the U.S. federal income tax treatment of any cash settlement payment we receive is uncertain. In the event that we recognize a significant gain from the cash settlement of a forward equity agreement, we might be unable to satisfy the gross income requirements applicable to REITs under the Internal Revenue Code. In that case, we may be able to rely upon the relief provisions under the Internal Revenue Code in order to avoid the loss of our REIT status. Even if the relief provisions apply, we will be subject to a 100% tax on the greater of (i) the excess of 75% of our gross income (excluding gross income from prohibited transactions) over the amount of such income attributable to sources that qualify under the 75% test or (ii) the excess of 95% of our gross income (excluding gross income from prohibited transactions) over the amount of such gross income attributable to sources that qualify under the 95% test, multiplied in either case by a fraction intended to reflect our profitability. In the event that these relief provisions were not available, we could lose our REIT status under the Internal Revenue Code.
Paragraph 130 · 25% changed Every version of it
Qualification as a REIT involves the application of highly technical and complex provisions of the Internal Revenue Code for which only limited judicial and administrative authorities exist. Even a technical or inadvertent violation could jeopardize the Company’s REIT qualification. The Company’s continued qualification as a REIT will depend on the Company’s satisfaction of certain asset, income, organizational, distribution, stockholder ownership and other requirements on a continuing basis. In addition, the Company’s ability to satisfy the requirements to qualify as a REIT depends in part on the actions of third parties over which the Company has no control or only limited influence, including in cases where the Company owns an equity interest in an entity that is classified as a partnership for U.S. federal income tax purposes.
Paragraph 149 · 24% changed Every version of it
The present federal income tax treatment of REITs may be modified, possibly with retroactive effect, by legislative, judicial or administrative action at any time, which could affect the federal income tax treatment of an investment in the Company. The federal income tax rules that affect REITs are constantly under review by persons involved in the legislative process, the IRS and the U.S. Treasury Department, which results in statutory changes as well as frequent revisions to regulations and interpretations. Revisions in federal tax laws and interpretations thereof could cause the Company to change its investments and commitments and affect the tax considerations of an investment in the Company. There can be no assurance that new legislation, regulations, administrative interpretations or court decisions will not change the tax laws significantly with respect to the Company’s qualification as a REIT or with respect to the federal income tax consequences of qualification.

MD&A

212 paragraphs · 13 new · 57 reworded · 24 gone · 10-K Feb 13, 2026 against Feb 19, 2025
New paragraph Reworded (5% of its words or more) Same or nearly
Paragraph 55 · 47% changed
On •In January 7, 2025, the Company made a partial repayment received $14.9 million as payment towards the principal balance of $25 million its mortgage loan that matured on its $200 million Unsecured Term Loan due 2025. December 2, 2024.
Paragraph 120 · 47% changed
Depreciation and amortization expense Interest income decreased $55.6 $2.1 million, or 7.6%, from 12.9%, for the year ended December 31, 2025, compared to the prior year primarily as a result of the following activity: repayment and maturity of note receivables, partially offset by the addition of new mortgages receivables.
Paragraph 54 · 46% changed
The In 2025, the Company had no the following activity on its real estate acquisition activity for the year ended December 31, 2024. notes receivables:
Paragraph 67 · 45% changed
During 2024, 2025, the Company repurchased 30.8 million did not repurchase any shares of its common stock at an average price of $16.56 per share for a total of $509.8 million. stock. As of December 31, 2024, 2025, the Company had $237.0 $500.0 million of authorized remaining under its current share repurchases remaining. repurchase authorization.
Paragraph 56 · 43% changed
4The •In March 2025, the Company provided seller financing of approximately $9.6 $5.4 million in connection with this sale. the sale of a real estate property in Houston, Texas.
Paragraph 60 · 43% changed
4The •In December 2025, the Company provided seller financing of approximately $9.6 $6.4 million in connection with this sale. the sale of a real estate property in Houston, Texas.
Paragraph 140 · 40% changed
Impairment of real estate assets in 2024 During the year ended December 31, 2025, the Company recognized impairments totaling approximately $249.9 $361.1 million is associated with related to completed or planned disposition activity. Additionally, dispositions, changes in holding periods or changes in property use. In addition, the Company recorded $59.5 $1.6 million of in credit loss reserves on its relating to a mortgage note receivables notes receivable and a $4.1 $1.9 million fair value adjustment for an equity investment in other assets.
Paragraph 138 · 38% changed
•The Unsecured Credit Facility repayment of the Senior Note due 2025 accounted for a decrease of approximately $11.4 $6.5 million.

A paragraph is matched with the one last year that shares the most of its words; under half in common makes it new. The paragraphs shown are the 8 reworded the most in each section.

The paragraph that changed most in each section

The redline

Marked against last year's 10-K: cut words struck through, new words highlighted.

Accounting Policies148 words changed in this paragraph; it is 64% similar to last year's version.
Pursuant to ASC Topic 326, Financial Instruments - Credit Losses, the Company adopted a policy to evaluate current expected credit losses at the inception of loans qualifying for treatment under ASC Topic 326. The Company utilizes a probability of default method approach for estimating current expected credit losses and evaluates the liquidity and creditworthiness of its borrowers on a quarterly basis to determine whether any updates to the future expected losses recognized upon inception are necessary. The Company’s evaluation considers industry and economic conditions, credit enhancements, liquidity, and other factors. The determination of the credit allowance is based on a quarterly evaluation of all outstanding loans, including general economic conditions and estimated collectability of loan payments. The Company evaluates the collectability of loan receivables based on a combination of credit quality indicators, including, but not limited to, payment status, historical loan charge-offs, financial strength of the borrower and guarantors, and nature, extent, and value of the underlying collateral. A loan is considered to have deteriorated credit quality when, based on current information and events, it is probable that the Company will be unable to collect all amounts due as scheduled according to the contractual terms of the loan agreement. For those loans identified as having deteriorated credit quality, the amount of credit loss is determined on an individual basis. Placement on non-accrual status may be required. Consistent with this definition, all loans on non-accrual status are deemed to have deteriorated credit quality. To the extent circumstances improve and the risk of collectability is diminished, the loan may return to income accrual status. While a loan is on non-accrual status, any cash receipts are applied against the outstanding principal balance.

Source: Item 8, Note 1 – Summary of Significant Accounting Policies, 10-K 0001360604-26-000018 vs Item 8, Note 1 – Summary of Significant Accounting Policies, 10-K 0001360604-25-000032

MD&A138 words changed in this paragraph; it is 34% similar to last year's version.
On January 11, 2025, As previously disclosed, Prospect Medical Holdings filed petitions for relief under Chapter 11 of the U.S. Bankruptcy Code in the U.S. Bankruptcy Court for the Northern District January of Texas. 2025. Prospect leases leased approximately 80,912 square feet of space from the Company, accounting Company. In October of 2025, a subsidiary of Hartford Health was selected as the successful bidder for approximately $2.9 million of annual revenue. the Prospect assets associated with the Company’s Prospect leases. The Company moved to cash basis accounting for these leases and recorded a reserve of $0.7 million in the fourth quarter. While it is early in the bankruptcy proceedings and the Company is in discussions with Prospect regarding its signed direct leases with the Company, there can be Hartford Heath totaling 65,477 square feet effective January 1, 2026 and retained certain sublet in additional spaces. There is no assurance that the Company will recover unpaid rent from Prospect. be able to timely relet the remaining Prospect leased space that was not assumed by Hartford Health.

Source: Item 7, 10-K 0001360604-26-000018 vs Item 7, 10-K 0001360604-25-000032

Risk Factors120 words changed in this paragraph; it is 36% similar to last year's version.
The Company had approximately $111.4 $55.7 million, or 0.94%, 0.54%, of real estate property investments that were subject to purchase options held by lessees that were exercisable as of December 31, 2024. 2025. Other properties have purchase options that will become exercisable after 2024. Properties with purchase options exercisable in 2024 produced aggregate net operating income of approximately $10.6 million in 2024. The exercise of these purchase options exposes the Company to reinvestment risk and a reduction in investment return. Certain properties subject to purchase options may be purchased at rates of return above the rates of return the Company expects to achieve with new investments. If the Company is unable to reinvest the sale proceeds at rates of return equal to the return received on the properties that are sold, it may experience a decline in lease revenues and profitability and a corresponding material adverse effect on the Company’s consolidated financial condition and results of operations.

Source: Item 1A, 10-K 0001360604-26-000018 vs Item 1A, 10-K 0001360604-25-000032

Legal Proceedings3 words changed in this paragraph; it is 98% similar to last year's version.
Land held for development includes parcels of land owned by the Company, upon which the Company intends to develop and own outpatient healthcare facilities. The Company's land held for development included 17 parcels as of December 31, 2025 and 15 parcels as of December 31, 2024 and 17 parcels as of December 31, 2023. 2024. The Company’s investments in land held for development totaled approximately $57.5 million as of December 31, 2025 and $52.4 million as of December 31, 2024 and $59.9 million as of December 31, 2023. 2024. The current land held for development is located adjacent to certain of the Company's existing medical office buildings in Colorado, Connecticut, Florida, Georgia, Massachusetts, New York, North Carolina, Tennessee, Texas, and Washington.

Source: Item 3, via Note 14 – Commitments and Contingencies, 10-K 0001360604-26-000018 vs Item 3, via Note 15 – Commitments and Contingencies, 10-K 0001360604-25-000032

Sentences and paragraphs added, removed or reworded

Every change, by type

Sentences and paragraphs of HR's Risk Factors and MD&A, 10-K Feb 13, 2026 against 10-K Feb 19, 2025. Each links to the text at sec.gov.

Quiet changes are sentences kept from last year with one to four words changed, at least one of them a hedge, a modal or a qualifier (may, could, will, not, significant, material…). A year or date rolling forward is not counted.

The full word list

adverse, adversely, all, although, anticipate, anticipates, any, approximately, believe, believes, can, cannot, certain, could, expect, expects, generally, however, if, intend, intends, largely, likely, many, material, materially, may, might, most, must, never, no, not, possible, primarily, probable, should, significant, significantly, some, substantial, substantially, unlikely, will, would

AddedRisk Factors
rates and operational requirements; unanticipated difficulties and/or expenditures relating to future acquisitions and developments; changes in rules or practices governing the Company's financial reporting; and other financial, legal and operational matters.
Read it in 10-K Feb 13, 2026 at sec.gov
AddedRisk Factors
The Company had approximately $55.7 million, or 0.54%, of real estate property investments that were subject to purchase options held by lessees that were exercisable as of December 31, 2025. Other properties have purchase
Read it in 10-K Feb 13, 2026 at sec.gov
RemovedRisk Factors
As previously disclosed, on May 6, 2024, Steward Health announced that it had filed petitions for relief under Chapter 11 of the U.S. Bankruptcy Code in the U.S. Bankruptcy Court for the Southern District of Texas. Prior to the bankruptcy filing, Steward leased approximately 593,000 square feet of space from the Company, accounting for approximately 2.0% of the Company’s rental revenue. Leases for six buildings in Massachusetts totaling approximately 244,000 square feet were assumed in connection with the sale of Steward’s Massachusetts hospitals on or about September 30, 2024. In October 2024, the Company received $2.2 million for prior rent owed under these assumed leases.
Read it in 10-K Feb 19, 2025 at sec.gov
RemovedRisk Factors
Leases for approximately 349,000 square feet in buildings in Florida and Massachusetts were rejected by Steward. The total annual revenue associated with the rejected leases was approximately $13.0 million.
Read it in 10-K Feb 19, 2025 at sec.gov
RemovedRisk Factors
The Company will pursue claims for outstanding rent of approximately $2.3 million against Steward in the bankruptcy court. However, there can be no assurance that the Company will recover unpaid rent from Steward be able to timely relet space related to rejected leases at similar rental rates, or otherwise offset lost revenue from Steward Health.
Read it in 10-K Feb 19, 2025 at sec.gov
RemovedRisk Factors
The Company's former Chief Executive Officer departed the Company in the second half of 2024. The Company's board of directors is currently conducting a search for a chief executive officer. While the board is actively engaged in the process and is utilizing a reputable national search firm, there can be no assurances as to the timing of the appointment of a CEO. Uncertainty concerning the appointment of a CEO could affect the Company's stock performance and its ability to attract, retain, and motivate key personnel needed to execute operational priorities.
Read it in 10-K Feb 19, 2025 at sec.gov
Show the other 49
RewordedRisk Factors
Although we believe that any amount received by us in exchange for our stock would qualify for the exemption under Section 1032 of the Internal Revenue Code, because it is not entirely clear whether a forward equity agreement qualifies as a "securities futures contract," the U.S. federal income tax treatment of any cash settlement payment we receive is uncertain.
Read it in 10-K Feb 13, 2026 at sec.gov
RewordedRisk Factors
This may be the result of various factors, including, but not limited to: changes in the economy; the availability and cost of capital at favorable rates; increases in property taxes, utilities and other operating expenses; changes to facility-related healthcare regulations; changes in interest rates; competition for quality assets; negative developments in the operating results or financial condition of the Company's tenants, including, but not limited to, their ability to pay rent; the Company's ability to reposition or sell facilities with profitable results; the Company's ability to re-lease space at similar rates as vacancies occur; the Company's ability to timely reinvest proceeds from the sale of assets at similar yields; government regulations affecting tenants' Medicare and Medicaid reimbursement rates and operational requirements; unanticipated difficulties and/or expenditures relating to future acquisitions and developments; changes in rules or practices governing the Company's financial reporting; and other financial, legal and operational matters.
Read it in 10-K Feb 13, 2026 at sec.gov
RewordedRisk Factors
There can be is no assurance that the Company will recover unpaid rent from Prospect or be able to timely relet the remaining Prospect leased space related to any rejected leases. that was not assumed by Hartford Health.
Read it in 10-K Feb 13, 2026 at sec.gov
RewordedRisk Factors
In addition, the deterioration of economic conditions, including supply chain constraints, that could result from another pandemic may ultimately decrease occupancy levels and average rent per square foot across the Company's portfolio as tenants reduce or defer their spending.
Read it in 10-K Feb 13, 2026 at sec.gov
RewordedRisk Factors
In addition, changes in federal and state legislation and regulation on climate change could result in increased capital expenditures to improve energy efficiency of our existing properties and could require the Company to spend more on development and redevelopment properties without a corresponding increase in revenue.
Read it in 10-K Feb 13, 2026 at sec.gov
RewordedRisk Factors
Trends in the healthcare service industry industry, including the impact of the One Big Beautiful Bill Act passed during 2025 that is subject of ongoing analysis, may negatively affect the demand for the Company’s properties, lease revenues and the values of its investments.
Read it in 10-K Feb 13, 2026 at sec.gov
RewordedRisk Factors
The Company incurred impairment charges of $249.9 $361.1 million in 2024, associated with 2025, related to completed or planned disposition activity. dispositions, changes in holding periods or changes in property use.
Read it in 10-K Feb 13, 2026 at sec.gov
RewordedRisk Factors
As of December 31, 2024, 2025, the Company had investment concentrations of greater than 5% of its total investments in the Dallas, TX (8.5%), (9.5%), Seattle, WA (6.1%), Houston, TX (5.4%), (6.0%), and Seattle, WA (5.2%) Charlotte, NC (5.4%) markets.
Read it in 10-K Feb 13, 2026 at sec.gov
RewordedRisk Factors
As of December 31, 2024, 2025, the Company had investments of $473.1 $453.6 million in unconsolidated joint ventures with unrelated third parties comprised of 63 properties 61 properties, excluding held for sale properties, and seven parking garages.
Read it in 10-K Feb 13, 2026 at sec.gov
RewordedRisk Factors
If this such an initiative had passed, it would have ended could end or reduce the beneficial effect of Proposition 13 for the Company's properties, and property tax expense could have increase substantially, adversely affecting the Company's cash flow from operations and net income.
Read it in 10-K Feb 13, 2026 at sec.gov
AddedMD&A
•In March 2025, the Company executed a mezzanine loan receivable agreement with a maximum loan commitment of $8.5 million. As of December 31, 2025, the Company had funded the full $8.5 million under this agreement.
Read it in 10-K Feb 13, 2026 at sec.gov
AddedMD&A
6The Company sold six MOBs in El Paso, TX, four MOBs in Indianapolis, IN, two MOBs in each of Chicago, IL, Cincinnati, OH, Des Moines, IA, Fort Wayne, IN, Minneapolis, MN and Pittsburgh, PA; and one MOB in each of Detroit, MI, Las Vegas, NV and Salt Lake City, UT to a single buyer in a single transaction.
Read it in 10-K Feb 13, 2026 at sec.gov
AddedMD&A
On December 17, 2025, the Company renewed its ATM equity offering program to sell shares of the Company's common stock from time to time in at-the-market sales transactions. The Company entered into equity distribution agreements with various sales agents having an aggregate offering price of up to $1.0 billion. As of December 31, 2025, there has been no activity under the program.
Read it in 10-K Feb 13, 2026 at sec.gov
AddedMD&A
During the year ended December 31, 2025, the Company repaid in full a mortgage note payable bearing interest at a rate of 4.25% that encumbered a 45,157 square foot property in California.
Read it in 10-K Feb 13, 2026 at sec.gov
AddedMD&A
In February 2026, the Company entered into a commercial paper dealer agreement to issue short-term commercial paper notes up to $600.0 million, with maturities up to 364 days. The program is back-stopped by the Unsecured Credit Facility. The notes will be issued at par less a discount representing an interest factor, or if interest bearing, at par.
Read it in 10-K Feb 13, 2026 at sec.gov
AddedMD&A
As previously disclosed, Prospect filed petitions for relief under Chapter 11 of the U.S. Bankruptcy Code in January of 2025. Prospect leased approximately 80,912 square feet of space from the Company. In October of 2025, a subsidiary of Hartford Health was selected as the successful bidder for the Prospect assets associated with the Company’s Prospect leases. The Company signed direct leases with Hartford Heath totaling 65,477 square feet effective January 1, 2026 and retained certain sublet in additional spaces. There is no assurance that the Company will be able to timely relet the remaining Prospect leased space that was not assumed by Hartford Health.
Read it in 10-K Feb 13, 2026 at sec.gov
AddedMD&A
During the year ended December 31, 2025, the Company recorded approximately $0.5 million in debt extinguishment costs related to the Unsecured Credit Facility, which replaced the Company's prior credit facility.
Read it in 10-K Feb 13, 2026 at sec.gov
AddedMD&A
During 2025, the Company recorded approximately $4.3 million from Accumulated other comprehensive income ("AOCI") to other expense related to ineffectiveness and subsequent termination of eight interest rate swaps. See Note 10 to the Consolidated Financial Statements in this report for more details regarding the Company's derivative accounting.
Read it in 10-K Feb 13, 2026 at sec.gov
AddedMD&A
In addition, the Company recognized income of approximately $0.8 million primarily due to a Federal ERC program (Employee Retention Credit) providing cash payment for employee retention during the COVID-19 pandemic totaling $4.4 million, net of a charge for a merger-related transfer tax charge that was finalized during the fourth quarter of 2025 totaling $3.6 million.
Read it in 10-K Feb 13, 2026 at sec.gov
RemovedMD&A
As described in Item 1. Business above and elsewhere in this report, on July 20, 2022, Legacy HR and Legacy HTA completed a merger between the companies in which Legacy HR merged with and into a wholly-owned subsidiary of Legacy HTA, with Legacy HR continuing as the surviving entity and a wholly-owned subsidiary of Legacy HTA. Immediately following the Merger, Legacy HTA changed its name to “Healthcare Realty Trust Incorporated.” For accounting purposes, the Merger was treated as a “reverse acquisition” in which Legacy HR was considered the acquirer. Accordingly, the information discussed in this section reflects, for periods prior to the closing of the Merger, the financial condition and results of operations of Legacy HR, and for periods from the closing of the Merger, that of the Company.
Read it in 10-K Feb 19, 2025 at sec.gov
RemovedMD&A
In 2024, the Company's investment in unconsolidated joint ventures increased by $172.7 million, as a result of the Company's contribution of medical outpatient properties to two joint ventures in which it holds a 20% interest.
Read it in 10-K Feb 19, 2025 at sec.gov
RemovedMD&A
On June 24, 2024, the Company's two mezzanine loans in Texas with a total principal balance of $54.1 million matured. On July 15, 2024, the senior lender on the construction mortgage loans associated with the underlying project initiated foreclosure proceedings to the borrower. In the third quarter of 2024, the Company recorded an allowance for credit loss of $46.8 million to cover the entire carrying amount for these loans. The Company had
Read it in 10-K Feb 19, 2025 at sec.gov
RemovedMD&A
previously placed the mezzanine loans on non-accrual status in 2023. In the fourth quarter of 2024, the underlying project was sold, and the Company received $4.0 million as consideration for its mezzanine loan interests. The Company no longer has a mezzanine loan position in connection with the project.
Read it in 10-K Feb 19, 2025 at sec.gov
RemovedMD&A
In 2024, the Company placed one of its real estate notes receivable with a principal balance of $31.2 million on non-accrual status. The Company determined that the risk of credit loss was no longer remote and recorded a credit loss reserve of $16.8 million including $0.5 million of accrued interest in 2024. In January 2025, the underlying real estate collateral was sold and the Company received $14.9 million towards the principal balance of this loan.
Read it in 10-K Feb 19, 2025 at sec.gov
RemovedMD&A
1The Company contributed the following medical outpatient properties to a joint venture in which the Company retained 20% ownership: one in each of Raleigh, NC, New York, NY, Philadelphia, PA, Atlanta, GA, Austin, TX, Miami, FL, Denver, CO, Memphis, TN, Indianapolis, IN, and Honolulu, HI; two MOBs in Los Angeles; three MOBs in Houston, TX and Dallas, TX; and five in Seattle, WA. Sale price and square footage reflect the total sale price paid by the joint venture and total square footage of the property. The net proceeds to the Company related to these dispositions totaled $584.9 million.
Read it in 10-K Feb 19, 2025 at sec.gov
RemovedMD&A
3The Company contributed the following medical outpatient properties to a joint venture in which the Company retained 20% ownership: one in each of Dallas, TX, San Antonio, TX and Atlanta, GA; and two MOBs in each of Nashville, TN and Denver, CO. Sale price and square footage reflect the total sale price paid by the joint venture and total square footage of the property. The net proceeds to the Company related to these dispositions totaled $148.9 million.
Read it in 10-K Feb 19, 2025 at sec.gov
RemovedMD&A
5The Company sold an MOB that was included in a consolidated joint venture in which the Company held a 63% ownership interest. Proceeds include the Company's pro-rata share of the purchase price as well as amounts due to the Company by the joint venture.
Read it in 10-K Feb 19, 2025 at sec.gov
RemovedMD&A
The following table details the mortgage note repayment activity for the year ended December 31, 2024:(dollars in millions) TRANSACTION DATE PRINCIPAL BORROWING (REPAYMENT) ENCUMBERED SQUARE FEET CONTRACTUAL INTEREST RATE Mortgages repaid at maturity: West Hills, CA 1/6/2024 $ (11.3) 63,012 4.77% Atlanta, GA 2/1/2024 (5.6) 40,324 4.12% Minnesota 9/1/2024 (7.0) 64,143 4.15% Total repayments $ (23.9) 167,479 4.44%
Read it in 10-K Feb 19, 2025 at sec.gov
RewordedMD&A
YEAR ENDED DECEMBER 31, Amounts in thousands, except per share data 2025 2024 2023 2022 Net (loss) income loss attributable to common stockholders $ (246,071) $ (654,485) $ (278,261) $ 40,897 Net (loss) income loss attributable to common stockholders per diluted share 1 $ (0.71) $ (1.81) $ (0.74) $ 0.15 Gain on sales of real estate assets (235,389) (104,684) (77,546) (270,271) Impairment of real estate properties 361,090 249,909 149,717 54,427 Real estate depreciation and amortization 586,146 690,988 738,526 459,211 Non-controlling loss from operating partnership units (3,497) (9,149) (3,426) (5) Unconsolidated JV depreciation depreciation, amortization and amortization impairment 27,769 20,678 18,116 12,722 FFO adjustments $ 736,119 $ 847,742 $ 825,387 $ 256,084 FFO adjustments per common share - diluted $ 2.08 $ 2.29 $ 2.15 $ 1.01 FFO attributable to common stockholders $ 490,048 $ 193,257 $ 547,126 $ 296,981 FFO attributable to common stockholders per common share - diluted $ 1.38 $ 0.52 $ 1.43 $ 1.17 — Transaction costs 2,029 3,122 2,026 3,229 Merger-related costs 2 — — (1,952) 103,380 Lease intangible amortization (1,350) (2,054) 860 1,028 Non-routine tax and legal costs/forfeited earnest money received matters (118) 1,077 175 771 Debt financing costs 2 5,107 237 (62) 3,145 Restructuring and severance-related charges 26,318 29,852 1,445 — Credit losses and gains (losses) on other assets, net 3 3,508 59,707 8,599 — Impairment of goodwill — 250,530 — — Merger-related fair value of debt instruments 42,593 40,667 42,885 21,248 Unconsolidated JV normalizing items 4 811 390 389 330 Normalized FFO adjustments $ 78,898 $ 383,528 $ 54,365 $ 133,131 Normalized FFO adjustments per common share - diluted $ 0.22 $ 1.04 $ 0.14 $ 0.52 Normalized FFO attributable to common stockholders $ 568,946 $ 576,785 $ 601,491 $ 430,112 Normalized FFO attributable to common stockholders per common share - diluted $ 1.61 $ 1.56 $ 1.57 $ 1.69 Non-real estate depreciation and amortization other amortization, net 6,114 1,478 2,566 2,217 Non-cash interest amortization, net 5 5,126 5,101 4,968 5,129 Rent reserves, net 952 714 3,163 516 Straight-line rent, net (29,392) (27,254) (32,592) (20,124) Stock-based compensation 13,609 14,036 13,791 14,294 Unconsolidated JV non-cash items 6 (1,420) (923) (1,034) (1,206) Normalized FFO adjusted for non-cash items $ 563,935 $ 569,937 $ 592,353 $ 430,938 2nd generation tenant improvements (47,438) (69,445) (66,081) (33,620) Leasing commissions paid (31,664) (47,450) (36,391) (22,929) Building capital (36,531) (33,934) (49,343) (48,913) FAD $ 448,302 $ 419,108 $ 440,538 $ 325,476 FFO weighted average common shares outstanding - diluted 7 354,454 369,767 383,381 254,622
Read it in 10-K Feb 13, 2026 at sec.gov
RewordedMD&A
AS OF DECEMBER 31, 2024 2025 Dollars and square feet in thousands PROPERTY COUNT GROSS INVESTMENT 1 SQUARE OCCUPANCY FEET Same store properties 556 473 $ 10,810,884 31,850 89.8% 9,172,301 26,303 92.2% Joint venture same store properties 29 322,639 1,636 89.2% 28 313,552 1,532 90.1% Wholly owned and joint venture acquisitions 33 172,330 2,388 94.3% 30 183,779 2,193 95.3% Wholly owned and joint venture development re/development completions 5 191,113 553 57.7% 4 139,279 332 60.8% Wholly owned and joint venture redevelopments 25 545,331 1,874 63.0% Planned Dispositions 3 50,245 144 58.3% re/developments 27 796,431 2,371 70.0% Total 651 562 $ 12,092,542 38,445 88.2% 10,605,342 32,731 90.4% Joint venture properties 65 556,897 4,253 87.4% 63 608,367 4,113 89.7% Total wholly-owned real estate properties 586 499 $ 11,535,645 34,192 88.3% 9,996,975 28,618 90.5%
Read it in 10-K Feb 13, 2026 at sec.gov
RewordedMD&A
During 2024, the year ended December 31, 2025, the Company repaid its $350 the $300 million Unsecured Term Loan, Loan due 2025 January 2026, the $200 million Unsecured Term Loan due January 2026, and recognized the $150 million Unsecured Term Loan due June 2026 and recorded approximately $0.2 $0.5 million of accelerated amortization expense included in the loss on extinguishment of debt.
Read it in 10-K Feb 13, 2026 at sec.gov
RewordedMD&A
During the first quarter of 2024, the The Company determined that the carrying value of its single reporting unit exceeded estimated fair value and therefore recorded a $250.5 million full impairment of its goodwill, which is recorded as a non-cash charge in “Impairment of goodwill” in the consolidated statements Consolidated Statement of operations. Operations for the year ended December 31, 2024.
Read it in 10-K Feb 13, 2026 at sec.gov
RewordedMD&A
Accordingly, as permitted under Rule 13-01(a)(4)(vi) of Regulation S-X, the Company has excluded the summarized financial information for the OP because the assets, liabilities, and results of operations of the OP are not materially different than the corresponding amounts in the Company's Consolidated Financial Statements and management believes such summarized financial information would be repetitive and would not provide incremental value to investors.
Read it in 10-K Feb 13, 2026 at sec.gov
RewordedMD&A
The Company recorded impairment charges totaling $361.1 million and $249.9 million million, respectively, for the year years ended December 31, 2024 2025 and December 31, 2024, related to real estate properties sold and other long-lived assets. properties with changes in the expected holding periods.
Read it in 10-K Feb 13, 2026 at sec.gov
RewordedMD&A
Other operating income increased $1.7 $9.1 million, or 9.8%, from 47.3%, for the year ended December 31, 2025, compared to the prior year primarily as a result of income from management fees. fees related to unconsolidated joint ventures and managed properties.
Read it in 10-K Feb 13, 2026 at sec.gov
RewordedMD&A
The In addition, the Company expensed costs related to the pursuit of acquisitions developments totaling $1.0 million, $1.1 million, and dispositions totaling $1.7 million, $0.8 million and $1.0 million for the years ended December 31, 2024, 2023 2025, 2024 and 2022, 2023, respectively.
Read it in 10-K Feb 13, 2026 at sec.gov
RewordedMD&A
During 2024, In January 2026, the Company repurchased 30.8 2.9 million shares of its common stock at an average price of $16.56 $17.27 per share for a total of $509.8 million. $50.0 million resulting in $450.0 million of authorized share repurchases remaining.
Read it in 10-K Feb 13, 2026 at sec.gov
RewordedMD&A
These transactions yielded net cash proceeds of $1.2 approximately $1.0 billion, net of $67.3 approximately $77.6 million of closing costs and related adjustments adjustments, and $172.7 $11.8 million of retained joint venture interests. in Company financed notes.
Read it in 10-K Feb 13, 2026 at sec.gov
RewordedMD&A
Additionally, In addition, the Company recorded $59.5 $1.6 million of in credit loss reserves on its relating to a mortgage note receivables notes receivable and a $4.1 $1.9 million fair value adjustment for an equity investment in other assets.
Read it in 10-K Feb 13, 2026 at sec.gov
RewordedMD&A
Impairment of real estate assets in 2024 totaling approximately $249.9 million is associated with related to completed or planned disposition activity. dispositions, changes in holding periods or changes in property use.
Read it in 10-K Feb 13, 2026 at sec.gov
Quiet changesMD&A
However, during During the first quarter of 2024, the Company experienced a sustained decline in the price per share of its common stock, which was identified as an indicator of goodwill impairment.
Read it in 10-K Feb 13, 2026 at sec.gov

Sources

The two latest 10-Ks on EDGAR, section by section. Each change links to the text at sec.gov.

Also

New risk factors: paragraphs with nothing like them last year, quoted in full.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/HR/export.csv") into a cell.

Next:Related parties
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.